Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 260

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases

Open access
Ross, Christopher A. · 1995 · Neuron

Abstract

Christopher A. Ross Laboratory of Molecular Neurobiology Departments of Psychiatry and Neuroscience Program in Cellular and Molecular Medicine Johns Hopkins Medical School Baltimore, Maryland 21205 Five neurodegenerative diseases are caused by ex- panding CAG triplet repeats coding for polyglutamine. They all involve loss of selected populations of neurons, usually in adulthood. How the genetic lesions cause pro- gressive neuronal degeneration is unknown. Unraveling the pathogenesis of these disorders will help elucidate pathways of neuronal cell death. Triplet repeat disorders involve the recently identified phenomenon of unstable DNA, in which repeating units of 3 nucleotides such as CAG expand during vertical trans- mission and cause disease (La Spada et al., 1994). They can be divided into two types. The first type (Figure 1) involves expanding CAG repeats coding for polygluta- mine. The normal length of the repeat is from 6 or 7 to about 30, and the disease is present when the repeat expands to 35-40 or more. Except for the androgen receptor of spinal and bulbar muscular atrophy (SBMA), none of the caus- ative genes has a known function or substantial homology with any known gene in the database. In the second type of disease (Table 1), triplet repeats such as CTG or CCG are present in mRNA outside the open reading frame (La Spada et al., 1994; Ross et al., 1993). In all of the glutamine repeat diseases, there is loss of neurons with gliosis, but without deposition of extracellular material or intracellular inclusion bodies. Though the ex- pression patterns of the causative genes are widespread, the disorders involve loss of neurons within specific re- gions of the brain and spinal cord (Figure 1). It is possible that the glutamine repeat diseases share similar mecha- nisms of pathogenesis. Glutamine Repeat Diseases and Causative Genes Huntington's disease (HD) is the most common glutamine repeat disease. It is an autosomal dominant neurodegen- erative disorder characterized by abnormal movements including chorea, dementia, and emotional disorders. The pathology is notable for selective neuronal vulnerability of medium spiny projection neurons in the caudate and putamen. After a long search, the HD gene was identified and found to have an expanding CAG repeat (Huntington's Disease Collaborative Research Group, 1993). The mRNA contains a long open reading frame coding for a predicted protein of 348 kDa. Immediately adjacent to the glutamine repeat, there are two proline repeats interrupted by a pro- line-rich region. The protein product of the HD gene (hun- tingtin), like the mRNA, has a widespread expression in both the brain and the periphery (Sharp et al., 1995; Trot- tier et al., 1995). Within the brain, it is predominantly neu- ronal with no enrichment in the basal ganglia. It is present in cell bodies and dendrites and appears enriched in neu- ronal terminals, possibly associated with vessicles or mi- crotubules (DiFiglia et al., 1995; Gutekunst et al., 1995). Dentato-Rubral and Pallido-Luysian Atrophy (DRPLA or Smith's Disease) is a rare neurodegenerative disorder whose clinical features for adult onset cases are similar to those of HD. DRPLA was the first triplet repeat disease- causing gene

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/0896-6273(95)90138-8

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 260

Metadata

Authors
Ross, C. A.
Venue
Neuron
Publisher
Elsevier BV
Published
1995-09
Volume
15
Issue
3
Pages
493-496
ISSN
0896-6273 (ISSN-L)
OpenAlex
W2069850109
Cited by
260
References
26
FWCI
11.69
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases. https://app.cochat.ai/papers/10.1016/0896-6273(95)90138-8
The paper
Ross, C. A. (1995). When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases. Neuron. https://doi.org/10.1016/0896-6273(95)90138-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.